BUY Mankind Pharma Limited — Rajesh Satpute
Mankind Pharma share price target & all analyst calls
byRajesh SatputeHorizon: BTST7 Oct 2026, 3:14 pm ISTvia CNBC Awaaz.
Entry₹2,500Inferred
Stop loss₹2,470-1.20% risk
Exit₹2,4708 Oct 2026, 9:38 am
Stop-loss hit-1.20%
Follow Rajesh Satpute for new calls(8% target hit, 124 closed calls)Get alertsWatch MANKIND for new buy/sell callsGet alertsSee 3 active BTST picks this session
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
0 supporting1 neutral0 opposing
Supports the BUY call (0)
Nothing found in this tip’s window yet.
Neutral / worth noting (1)
Weighs against the BUY call (0)
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Mankind Pharma
- BUY — Swati Hotkar, Nirmal Bang Securities7 Oct 2026 · Same day · target ₹2,580 · Expired
- SELL — Macquarie7 Oct 2026 · ~1 year · target ₹2,200 · Target hit
- BUY — Vishvesh Chauhan, ChaseAlpha30 Sept 2026 · ~2 weeks · target ₹2,640 · SL hit
- BUY — Raja Venkatraman30 Sept 2026 · ~3 months · target ₹2,800 · SL hit
- BUY — Shrikant Chouhan, Kotak Securities29 Sept 2026 · ~3 months · target ₹2,650 · Active
More from Rajesh Satpute
- BUY Chennai Petroleum Corporation23 Oct 2026 · ~2 weeks · target ₹1,600 · SL hit
- SELL Sona BLW Precision Forgings22 Oct 2026 · Same day · target ₹720 · SL hit
- BUY Nuvama Wealth Management21 Oct 2026 · ~2 weeks · target ₹1,740 · SL hit
- BUY Tech Mahindra21 Oct 2026 · Next day · target ₹1,850 · Expired
- BUY Reliance Industries21 Oct 2026 · Next day · target ₹1,245 · Expired